00:59:54 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-23 Kvartalsrapport 2024-Q3
2024-07-31 Kvartalsrapport 2024-Q2
2024-06-04 X-dag kvartalsutdelning NOBLE 2.75232
2024-05-21 Årsstämma 2024
2024-05-06 Kvartalsrapport 2024-Q1
2024-03-07 X-dag kvartalsutdelning NOBLE 2.73712
2024-02-22 Bokslutskommuniké 2023
2023-11-14 X-dag kvartalsutdelning NOBLE 2.81184
2023-10-31 Kvartalsrapport 2023-Q3
2023-08-16 X-dag kvartalsutdelning NOBLE 2.03463
2023-08-02 Kvartalsrapport 2023-Q2
2023-05-05 X-dag ordinarie utdelning NOBLE 0.00 DKK
2023-05-04 Kvartalsrapport 2023-Q1
2023-05-02 Årsstämma 2023
2023-02-26 Bokslutskommuniké 2022
2022-11-03 Kvartalsrapport 2022-Q3
2022-08-09 Kvartalsrapport 2022-Q2
2022-05-10 Extra Bolagsstämma

Beskrivning

LandStorbritannien
ListaLarge Cap Copenhagen
SektorRåvaror
IndustriOlja & gas
Noble är verksamt inom olje- och gassektorn. Bolaget är specialiserat inom offshore-borrning för olje- och naturgasindustrin. Tjänsterna erbjuds på kontraktsbasis genom en flotta av mobila offshore-borrningsenheter. Kunderna består huvudsakligen av stora industriella aktörer runtom den globala marknaden. Bolaget grundades 1921 och har sitt huvudkontor i Sugar Land, Texas.
2023-10-31 21:09:00

SUGAR LAND, TEXAS, October 31, 2023 /CNW/ - Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today updates its prior guidance.

In accordance with Danish legal and stock exchange requirements, Noble announced that for the full year 2023, it is increasing guidance for total revenue to a range of $2.5 to $2.6 billion (previously $2.35 to $2.55 billion) and Adjusted EBITDA to a range of $775 to $825 million (previously $725 to $825 million). Full year 2023 guidance for capital expenditures (net of reimbursable capex) remains unchanged at a range of $325 to $365 million.

Noble is releasing its third quarter earnings simultaneously with this update, please see the Third Quarter 2023 Earnings Release for additional details.

IMPORTANT INFORMATION
This announcement is for information purposes only and does not constitute or contain any invitation, solicitation, recommendation, offer or advice to any person to subscribe for or otherwise acquire or dispose of any securities of Noble.

This communication includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, as amended. All statements other than statements of historical facts included in this communication are forward looking statements, including those regarding future guidance, including revenue and adjusted EBITDA. Forward-looking statements involve risks, uncertainties and assumptions, and actual results may differ materially from any future results expressed or implied by such forward-looking statements. When used in this communication, or in the documents incorporated by reference, the words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "on track," "plan," "possible," "potential," "predict," "project," "should," "would," "shall," "target," "will" and similar expressions are intended to be among the statements that identify forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot assure you that such expectations will prove to be correct. These forward-looking statements speak only as of the date of this communication and we undertake no obligation to revise or update any forward-looking statement for any reason, except as required by law. Risks and uncertainties include, but are not limited to, those detailed in Noble's most recent Annual Report on Form 10-K, Quarterly Reports Form 10-Q and other filings with the U.S. Securities and Exchange Commission. We cannot control such risk factors and other uncertainties, and in many cases, we cannot predict the risks and uncertainties that could cause our actual results to differ materially from those indicated by the forward-looking statements. You should consider these risks and uncertainties when you are evaluating us.

View PDF Version (https://mb.cision.com/Public/21786/3866763/a9f74919079b311d.pdf)